Everest Medicines Ltd. is a biopharmaceutical company, which engages in the discovering, developing, manufacturing, and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asian markets. The company is headquartered in Shanghai, Shanghai and currently employs 722 full-time employees. The company went IPO on 2020-10-09. The firm has built a product pipeline across renal, anti-infective, and autoimmune diseases. The Company’s products portfolio includes Nefecon (TARPEYO) using in the renal therapeutic area, XERAVA (eravacycline) using in the treatment of infections caused by susceptible gram-positive, gram-negative and anaerobic pathogens including those multidrug resistant isolates and other products. The firm conducts its business in the domestic and overseas markets.
01952.HK stock price ended at $38.24 on Jueves, after dropping 2.85%
On the latest trading day Feb 12, 2026, the stock price of 01952.HK fell by 2.85%, dropping from $39.36 to $38.24. During the session, the stock saw a volatility of 4.03%, with prices oscillating between a daily low of $38.22 and a high of $39.76. On the latest trading day, the trading volume for 01952.HK rose by 37.1K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 1.5M shares were traded, with a market value of approximately $13.5B.
Señales Técnicas de 01952.HK
Resumen de Señales Técnicas
Señales de compra 2
Señales Neutras 2
Señales de venta 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
01952.HK actualmente presenta 2 señales de compra y 3 señales de venta. La acción ha estado en una tendencia bajista desde 12:00 AM, con un cambio total en el precio de -3.14% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Sell para el mediano plazo.
Señales alcistas/bajistas para 01952.HK
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para 01952.HK. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.